Carcinomas can be identified via immunostaining for p53, CD68 (Cluster of Differentiation 68), HBME-1 (Human Bone Marrow Endothelium Marker-1), and CK19 (Cytokeratin 19) [63,64,65]. This evidence concerns the gene TP53 and carcinoma.